Brief: Erytech Sells U.S. Manufacturing Facility For USD 44.5 Million

Phaxiam Therapeutics SA

25/04/2022 07:21

April 25 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH SELLS U.S. MANUFACTURING FACILITY AND ENTERS
LONG-TERM
SUPPLY AGREEMENT WITH CATALENT  CTLT.N 
    * CATALENT ACQUIRED ERYTECH'S U.S. CELL THERAPY
MANUFACTURING
FACILITY FOR A TOTAL CONSIDERATION OF USD 44.5 MILLION
    * ERYTECH AND CATALENT TO ENTER INTO A LONG-TERM SUPPLY
AGREEMENT
FOR CLINICAL AND COMMERCIAL SUPPLY OF ERYASPASE (GRASPA®)
    * TRANSACTION EXPECTED TO REDUCE OPERATING EXPENSES FOR
ERYTECH
    * TRANSACTION BRINGS ERYTECH'S CASH TO APPROXIMATELY EUR 55
MILLION (USD 60 MILLION), AND EXTENDS CASH RUNWAY TO MID-2024

Source text for Eikon:  urn:newsml:reuters.com:*:nGNXL1G2p
Further company coverage:  ERYP.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))